Back to DE D. E. Shaw & Co., Inc.

ANABANAB
27 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ANAPTYSBIO INC

D. E. Shaw & Co., Inc. holds 539,666 shares of ANAB (ANAPTYSBIO INC), worth $36.4M as of 2026-Q2. The position was decreased (-6.8% shares). ANAB represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$36.4M

Current Shares

539,666

Total Value Change

+$30.5M

Total Shares Change

+174,275

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
539,666
-6.8%
$36.4M0.0%$67.50
0
2026-Q1
Decreased
579,296
-13.6%
$32.1M0.0%$52.83
0
2025-Q4
Increased
670,288
+91.9%
$32.5M0.0%$48.23
46
2025-Q3
Increased
349,360
+211.0%
$10.7M0.0%$23.27
45
2025-Q2
Decreased
112,349
-13.3%
$2.5M0.0%$22.47
0
2025-Q1
Decreased
129,654
-34.2%
$2.4M0.0%$18.95
0
2024-Q4
Decreased
197,107
-12.1%
$2.6M0.0%$13.22
0
2024-Q3
Increased
224,137
+30.7%
$7.5M0.0%$31.87
35
2024-Q2
Decreased
171,450
-8.2%
$4.3M0.0%$25.06
0
2024-Q1
Increased
186,804
+16.5%
$4.2M0.0%$22.52
31
2023-Q4
Increased
160,326
+9.9%
$3.4M0.0%$21.42
29
2023-Q3
Decreased
145,892
-29.1%
$2.6M0.0%$17.96
0
2023-Q2
Decreased
205,796
-0.6%
$4.2M0.0%$20.26
0
2023-Q1
Increased
207,052
+18.9%
$4.5M0.0%$21.16
32
2022-Q4
Decreased
174,198
-1.3%
$5.4M0.0%$30.99
0
2022-Q3
Increased
176,500
+34.6%
$4.5M0.0%$26.05
35
2022-Q2
Decreased
131,152
-22.6%
$2.7M0.0%$20.63
0
2022-Q1
Decreased
169,560
-20.3%
$4.2M0.0%$24.51
0
2021-Q4
Decreased
212,681
-16.2%
$7.4M0.0%$35.31
0
2021-Q3
Decreased
253,792
-1.9%
$6.9M0.0%$26.53
0
2021-Q2
Decreased
258,644
-12.5%
$6.7M0.0%$25.69
0
2021-Q1
Decreased
295,594
-47.7%
$6.4M0.0%$20.23
0
2020-Q4
Decreased
564,925
-11.9%
$12.1M0.0%$21.88
0
2020-Q3
Decreased
640,946
-8.4%
$9.5M0.0%$14.71
0
2020-Q2
Increased
699,767
+52.8%
$15.6M0.0%$22.68
39
2020-Q1
Increased
458,061
+25.4%
$6.5M0.0%$14.14
33
2019-Q4
New
365,391
-
$5.9M0.0%$15.95
38

Other major holders of ANAB: ADAGE CAPITAL PARTNERS GP, L.L.C., BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used